Catalyst Wire Dossier Catalyst Wire Dossier

OXC XR

oxcarbazepine extended-release · Supernus Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for OXC XR, covering 2014-02-11 to 2017-05-31. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial Epilepsy [Phase 3]

See pricing